OPV1,monovalent type 1,vial of 20 doses

General Description:
Oral Polio Vaccine (OPV type 1), vial of 20 doses

Poliomyelitis vaccine, live, oral, monovalent, 20 dose presentation. Ready for use either in vial with dropper or in the form of dispenser, with vaccine vial monitor (VVM) affixed on to individual vial/dispenser. It is a monovalent vaccine containing suspension of type 1 attenuated poliomyielitis virus (Sabin strain).

For information on product specifications, refer to the WHO website on Prequalified Vaccines.

https://www.who.int/immunization_standards /vaccine_quality/PQ_vaccine_list_en/en/

Administration:
OPV must only be administered orally. Two drops are delivered directly into the mouth from the multi-dose vial by dropper or dispenser. For older children it may be preferred to avoid the possible bitter taste by first placing the drops on a sugar lump or in syrup. Care should be taken not to contaminate a multi-dose dropper with saliva of from the child being vaccinated.

Once opened, multi-dose vials should be stored under appropriate cold chain conditions (as recommended by the manufacturer). Multi-dose vials of OPV from which one or more doses of vaccine have been removed during an immunization session may be used in subsequent immunization sessions for up to a maximum of 4 weeks, provided that all of the following conditions are met (as described in the WHO policy statement: The use of opened multi-dose vials in subsequent immunization sessions. WHO/V &B/00.09

The expiry date has not passed;
the vaccines are stored under appropriate cold chain conditions;
the vaccine vial septum has not been submerged in water;
aseptic technique has been used to withdraw all doses;
the vaccine vial monitor (VVM) has not reached the discard point.

Immunization Schedule:
Monovalent Type 1 Oral Poliomyelitis Vaccine is indicated for poliomyelitis Supplementary Immunization Activities (SIAs) in children from 0 to 5 years of age, to interrupt type 1polovirus transmission in remaining polio endemic areas. The routine poliomyelitis vaccination programme should continue to use trivalent vaccines according to national policy.

Transport and Storage:
Vaccine is potent if stored at not higher than -20°C until the expiry date indicated on the vial. It can be stored for up to six months between +2°C and +8°C. The vaccine supplied in plastic tubes may change colour due to storage with dry ice; however this does not affect the quality of the vaccine.